E. Nigma
2013-01-23 02:06:07 UTC
Dear NCI Cancer Bulletin Subscriber,
We are writing to let you know that the NCI Cancer Bulletin online
newsletter will no longer be published. The decision was made as part of
the National Cancer Institutes ongoing efforts to examine how best to
apportion its limited cancer research resources.
Our final issue, published January 8, will remain live until the end of the
month. Our searchable archive of more than 5,000 news and feature stories
published since 2004 will remain on NCIs website, cancer.gov.
The editors, writers, and technical staff of the NCI Cancer Bulletin are
grateful for your interest in our publication and for your support over the
last 9 years. It has been our distinct pleasure to have brought you the
latest news about cancer researchincluding research supported by NCI,
other federal agencies, and institutions from across the nation and around
the world.
We hope you will continue to look to NCI for cancer research news and
information by visiting cancer.gov and using NCIs social media channels on
Twitter, Facebook, and YouTube.
Summaries highlighting recent results from cancer clinical trials that are
likely to influence clinical practice and summaries of featured clinical
trials supported by NCI will continue to be produced and published on
cancer.gov.
Please feel free to send us your comments at
***@mail.nih.gov.
Thank you again and best regards,
The NCI Cancer Bulletin Team
============================================================
So-Long,
E.
We are writing to let you know that the NCI Cancer Bulletin online
newsletter will no longer be published. The decision was made as part of
the National Cancer Institutes ongoing efforts to examine how best to
apportion its limited cancer research resources.
Our final issue, published January 8, will remain live until the end of the
month. Our searchable archive of more than 5,000 news and feature stories
published since 2004 will remain on NCIs website, cancer.gov.
The editors, writers, and technical staff of the NCI Cancer Bulletin are
grateful for your interest in our publication and for your support over the
last 9 years. It has been our distinct pleasure to have brought you the
latest news about cancer researchincluding research supported by NCI,
other federal agencies, and institutions from across the nation and around
the world.
We hope you will continue to look to NCI for cancer research news and
information by visiting cancer.gov and using NCIs social media channels on
Twitter, Facebook, and YouTube.
Summaries highlighting recent results from cancer clinical trials that are
likely to influence clinical practice and summaries of featured clinical
trials supported by NCI will continue to be produced and published on
cancer.gov.
Please feel free to send us your comments at
***@mail.nih.gov.
Thank you again and best regards,
The NCI Cancer Bulletin Team
============================================================
So-Long,
E.